Clinical evidence indicates sustained symptom relief in depression and PTSD, but challenges psychedelic treatments for mental health remain regarding safety, regulation, and optimal therapeutic protocols. The authors advocate for standardized protocols, enhanced safety reporting, and strategies to manage expectancy effects that complicate efficacy interpretations. Longitudinal studies comparing psychedelic-assisted therapy with...